Missale G, Camarri E, Fici F, Agosti A, Di Murro R
Int J Clin Pharmacol Ther Toxicol. 1981 Jun;19(6):273-4.
Daily administration of 900 mg dihydroxydibutylether (DHBE) produced a significant reduction of lithogenic index in patients with cholesterol gallstones. After treatment with placebo, in the same subjects the lithogenic index rises significantly. The activity of DHBE is not casual.